tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

EXAI Stock Latest News

Exscientia plc Calls for 2024 Shareholder Votes
Company AnnouncementsExscientia plc Calls for 2024 Shareholder Votes
3d ago
6K
EXAI
Exscientia files $300M mixed securities shelf
PremiumThe Fly
Exscientia files $300M mixed securities shelf
1M ago
EXAI
Exscientia Plc Reports Progressive Drug Pipeline
PremiumCompany Announcements
Exscientia Plc Reports Progressive Drug Pipeline
1M ago
6K
EXAI
Exscientia reports Q4 EPS (42c), consensus (35c)
PremiumThe Fly
Exscientia reports Q4 EPS (42c), consensus (35c)
1M ago
EXAI
EXAI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
EXAI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
EXAI
SHAREHOLDER ALERT: Potential Recovery for Exscientia plc (EXAI) Investors
PremiumClass ActionSHAREHOLDER ALERT: Potential Recovery for Exscientia plc (EXAI) Investors
2M ago
EXAI
Exscientia sinks 20% after CEO is fired for inappropriate relationships
PremiumThe Fly
Exscientia sinks 20% after CEO is fired for inappropriate relationships
2M ago
EXAI
Exscientia downgraded at BofA on limited near-term inflection opportunities
PremiumThe Fly
Exscientia downgraded at BofA on limited near-term inflection opportunities
4M ago
EXAI
Exscientia downgraded to Neutral from Buy at BofA
PremiumThe Fly
Exscientia downgraded to Neutral from Buy at BofA
4M ago
EXAI
Exscientia expands Sanofi deal, eligible for $45M in milestones plus incentives
PremiumThe Fly
Exscientia expands Sanofi deal, eligible for $45M in milestones plus incentives
4M ago
SNY
EXAI
Exscientia reports Q3 EPS (31c), consensus (40c)
PremiumThe Fly
Exscientia reports Q3 EPS (31c), consensus (40c)
6M ago
EXAI
Exscientia price target lowered to $10 from $12 at Barclays
PremiumThe Fly
Exscientia price target lowered to $10 from $12 at Barclays
6M ago
EXAI
Exscientia price target lowered to $11 from $16 at BofA
PremiumThe FlyExscientia price target lowered to $11 from $16 at BofA
7M ago
EXAI
Exscientia provided an update on its pipeline prioritisation strategy
PremiumThe Fly
Exscientia provided an update on its pipeline prioritisation strategy
7M ago
EXAI
Exscientia up 31% at $6.62 after entering drug discovery pact with Merck KGaA
PremiumThe Fly
Exscientia up 31% at $6.62 after entering drug discovery pact with Merck KGaA
7M ago
EXAI
Exscientia announces drug discovery pact with Merck KGaA
PremiumThe Fly
Exscientia announces drug discovery pact with Merck KGaA
7M ago
EXAI
Exscientia reports Q2 EPS (37c), consensus (35c)
PremiumThe Fly
Exscientia reports Q2 EPS (37c), consensus (35c)
9M ago
EXAI
Exscientia initiated with a Buy at Berenberg
PremiumThe Fly
Exscientia initiated with a Buy at Berenberg
9M ago
EXAI
Exscientia initiates prospective observational study in ovarian cancer
PremiumThe Fly
Exscientia initiates prospective observational study in ovarian cancer
9M ago
EXAI
Exscientia enrolls first patient in ELUCIDATE study
PremiumThe FlyExscientia enrolls first patient in ELUCIDATE study
10M ago
EXAI
GT Apeiron announces enrollment of first patient in Phase 1/2 ELUCIDATE study
PremiumThe Fly
GT Apeiron announces enrollment of first patient in Phase 1/2 ELUCIDATE study
10M ago
EXAI
Exscientia expands tech leadership team, CTO Pairaudeau stepping down
PremiumThe Fly
Exscientia expands tech leadership team, CTO Pairaudeau stepping down
10M ago
EXAI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >